Unnatural milieu: Thrombus after transcatheter mitral valve replacement
Key Points
What the article teaches
Transcatheter heart valve thrombosis in the mitral position causes increased valve gradients, valve dysfunction, and symptoms, and may be associated with lack of therapeutic anticoagulation.
How it will impact practice
Anticoagulation with a vitamin K antagonist should be considered in all patients undergoing transcatheter mitral valve replacement.
What new research/study would help answer the question posed
Efficacy, optimal duration, and safety of anticoagulation therapy, balancing reduced thrombosis against increased bleeding risk, needs to be assessed in larger cohort studies and prospective trials.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Jaffar M. Khan, Robert J. Lederman Tags: Valvular and Structural Heart Diseases Source Type: research
More News: Bleeding | Cardiac Catheterization | Cardiology | Cardiovascular | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Study | Teaching | Thrombosis | Vitamin K | Vitamins